This past year was a banner year for the life science industry. Amidst the ongoing pandemic, the life science industry experienced a surge in demand and access to both public and private capital. The year also included a number of legislative and tax incentive opportunities that benefit biotech and medical device companies. There is no […]
This blog contains general information and does not constitute the rendering of legal, accounting, investment, tax, or other professional services. Consult with your advisors regarding the applicability of this content to your specific circumstances.
Want to learn more? Complete the form below and we'll be in touch. If you are unable to see the form below, please complete your submission here.Contact us